Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PEPPI Study: Identification of Women at Risk for Placental Dysfunction During the First and Third Trimesters of Pregnancy

NCT06115122 is registered in ClinicalTrials.gov with Oulu University Hospital as lead sponsor.

NCT NCT06115122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06115122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PEPPI Study: Identification of Women at Risk for Placental Dysfunction During the First and Third Trimesters of Pregnancy
Lead sponsor
Oulu University Hospital
Phase
Observational
Overall status
Recruiting
Start date
February 15, 2022
Completion date
December 31, 2041
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, hypertensive disorder of pregnancy, intrauterine growth restriction, iron-deficiency, polycystic ovary syndrome, pre-eclampsia, proteinuria in pregnancy